{"name": "新生儿呼吸窘迫综合征", "summary": "新生儿呼吸窘迫综合征(respiratory distress syndrome of newborn，RDSN)，也称为肺透明膜病(hyaline membrane disease，HMD)，系指出生后不久即出现进行性呼吸困难、青紫、呼气性呻吟、吸气性三凹征和呼吸衰竭。主要见于早产儿，尤其是胎龄小于32～33 周。其基本特点为发育不成熟肺、肺表面活性物质缺乏而导致的进行性肺泡不张、肺液转运障碍、肺毛细血管-肺泡间高通透性渗出性病变。其病理特征为肺泡壁至终末细支气管壁上附有嗜伊红透明膜。以机械通气和呼吸机治疗为主的呼吸治疗和危重监护技术，已经能够使90%以上的RDSN患儿存活。", "is_insured": "否", "prevalence": "0.05%", "population": "新生儿", "infection": "无传染性", "complication": ["肺动脉高压", "呼吸衰竭", "心力衰竭", "肺气肿"], "department": ["儿科", "小儿内科"], "cure_mode": "药物治疗 支持性治疗", "cure_cycle": "2-4月", "cure_probability": "85%", "drug": ["盐酸氨溴索注射液", "盐酸氨溴索葡萄糖注射液"], "cure_cost": "根据不同医院，收费标准不一致，市三甲医院约（3000-10000元）", "kind_tips": "本病多见于早产儿，出生时胎时愈小，发病率愈高。在围生期窒息，急性产科出血如前置胎盘、胎盘早剥、双胎第二婴和母亲低血压时，肺透明膜病的发生率均显着增高。", "food": {"good": [], "bad": [], "recipe": []}}